Aurora A/B kinase inhibitors (Sareum)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameAurora A/B kinase inhibitors (Sareum)

Drug Alias NameSAR-2SAR-3

ClassificationSmall molecules

Mechanisms of ActionSerine/threonine-protein kinase Aurora-A inhibitorsAnticancer protein kinase inhibitorsSerine/threonine-protein kinase Aurora-B inhibitors

TargetsSerine/threonine-protein kinase Aurora-ASerine/threonine-protein kinase Aurora-B

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSareum Holdings plc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSareum Holdings plc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A